PALATIN TECHNOLOGIES INC (PTN)

US6960775020 - Common Stock

2.08  +0.08 (+4%)

Fundamental Rating

2

Taking everything into account, PTN scores 2 out of 10 in our fundamental rating. PTN was compared to 587 industry peers in the Biotechnology industry. PTN has a bad profitability rating. Also its financial health evaluation is rather negative. PTN is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year PTN has reported negative net income.
PTN had a negative operating cash flow in the past year.
In the past 5 years PTN reported 4 times negative net income.
PTN had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of PTN (-233.08%) is worse than 91.11% of its industry peers.
Industry RankSector Rank
ROA -233.08%
ROE N/A
ROIC N/A
ROA(3y)-101.35%
ROA(5y)-59.25%
ROE(3y)-9276.56%
ROE(5y)-5564.41%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 95.39%, PTN belongs to the best of the industry, outperforming 96.24% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for PTN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

PTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
PTN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, PTN has more shares outstanding
PTN has a worse debt/assets ratio than last year.

2.2 Solvency

PTN has an Altman-Z score of -50.03. This is a bad value and indicates that PTN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -50.03, PTN is not doing good in the industry: 94.02% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -50.03
ROIC/WACCN/A
WACC9.11%

2.3 Liquidity

PTN has a Current Ratio of 1.09. This is a normal value and indicates that PTN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.09, PTN is doing worse than 87.35% of the companies in the same industry.
PTN has a Quick Ratio of 1.09. This is a normal value and indicates that PTN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.09, PTN is doing worse than 86.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09

5

3. Growth

3.1 Past

PTN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.23%, which is quite good.
The Revenue has grown by 145.82% in the past year. This is a very strong growth!
The Revenue for PTN have been decreasing by -40.88% on average. This is quite bad
EPS 1Y (TTM)16.23%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-330.77%
Revenue 1Y (TTM)145.82%
Revenue growth 3Y243.18%
Revenue growth 5Y-40.88%
Revenue growth Q2Q97.49%

3.2 Future

PTN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.25% yearly.
PTN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 102.59% yearly.
EPS Next Y15.1%
EPS Next 2Y27.15%
EPS Next 3Y30.4%
EPS Next 5Y25.25%
Revenue Next Year-3.81%
Revenue Next 2Y29.42%
Revenue Next 3Y112.86%
Revenue Next 5Y102.59%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PTN. In the last year negative earnings were reported.
Also next year PTN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PTN's earnings are expected to grow with 30.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.15%
EPS Next 3Y30.4%

0

5. Dividend

5.1 Amount

PTN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PALATIN TECHNOLOGIES INC

NYSEARCA:PTN (5/7/2024, 7:18:21 PM)

2.08

+0.08 (+4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap33.57M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -233.08%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 95.39%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)16.23%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y15.1%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)145.82%
Revenue growth 3Y243.18%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y